Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91 publications
Using Lotilaner Ophthalmic Solution, 0.25% to Treat Demodex Blepharitis in Patients Who Were Initially Misdiagnosed: A Case Series.
Journal: Clinical optometry
Published: February 04, 2026
Effect of Cyclosporine Ophthalmic Solution 0.09% on Signs and Symptoms of Dry Eye Disease in Patients Inadequately Controlled on Cyclosporine Ophthalmic Emulsion 0.05%: Results from a Single-Arm, Open-Label, Phase 4 Study.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: November 20, 2025
Lotilaner ophthalmic solution 0.25% in the treatment of Demodex blepharitis: A case report.
Journal: SAGE open medical case reports
Published: November 14, 2025
Delphi panel on neuromodulation as a treatment strategy for dry eye disease: Unlocking the potential of natural tear production.
Journal: The ocular surface
Published: October 01, 2025
Real-World Experience with Lifitegrast Ophthalmic Solution in Patients with Dry Eye Disease: A Provider Survey in the USA and Canada.
Journal: Ophthalmology and therapy
Published: March 28, 2025
The Demodex Expert Panel on Treatment and Eyelid Health (DEPTH) Consensus Regarding the Preferred Treatment for Demodex Blepharitis.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: March 25, 2025
Evaluation of the Impact of Meibomian Gland Dysfunction Using a Novel Patient-Reported Outcome Instrument.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: November 01, 2023
Addressing excessive evaporation: an unmet need in dry eye disease.
Journal: The American journal of managed care
Published: October 16, 2023
The Phase 3 INVIGORATE Trial of Reproxalap in Patients with Seasonal Allergic Conjunctivitis.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: September 21, 2023
Exploring Signs and Symptoms Associated with Meibomian Gland Dysfunction for Use as Clinical Trial Endpoints.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: August 29, 2023
Relationship Between Human Meibum Lipid Composition and the Severity of Meibomian Gland Dysfunction: A Spectroscopic Analysis.
Journal: Investigative ophthalmology & visual science
Published: July 19, 2023
Last Updated: 09/26/2026